These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 21054569

  • 1. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group.
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [Abstract] [Full Text] [Related]

  • 3. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S, Macaluso L, Salvi M, Luci C, Mattozzi C, Marzocca F, Salvo V, Scarnò M, Calvieri S, Richetta AG.
    Clin Ter; 2014 Jun; 165(6):e395-400. PubMed ID: 25524193
    [Abstract] [Full Text] [Related]

  • 4. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
    Swartling C, Naver H, Pihl-Lundin I, Hagforsen E, Vahlquist A.
    J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H, Briand N, Bara C, Celerier P.
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [Abstract] [Full Text] [Related]

  • 6. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
    Bechara FG, Sand M, Achenbach RK, Sand D, Altmeyer P, Hoffmann K.
    Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
    [Abstract] [Full Text] [Related]

  • 7. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H.
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [Abstract] [Full Text] [Related]

  • 8. Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.
    Campanati A, Bernardini ML, Gesuita R, Offidani A.
    Eur J Dermatol; 2007 Dec; 17(1):52-4. PubMed ID: 17324828
    [Abstract] [Full Text] [Related]

  • 9. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ.
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [Abstract] [Full Text] [Related]

  • 10. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 11. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P, Moraru E, Kittler H, Voller B, Kranz G, Auff E.
    Wien Klin Wochenschr; 2001 Mar; 113 Suppl 4():36-41. PubMed ID: 15506051
    [Abstract] [Full Text] [Related]

  • 12. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE, Hayes WG, Nyamekye IK.
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [Abstract] [Full Text] [Related]

  • 13. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
    Ambrogi V, Campione E, Mineo D, Paternò EJ, Pompeo E, Mineo TC.
    Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
    [Abstract] [Full Text] [Related]

  • 14. Intravenous regional anesthesia (Bier's block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective.
    Blaheta HJ, Vollert B, Zuder D, Rassner G.
    Dermatol Surg; 2002 Aug; 28(8):666-71; discussion 671-2. PubMed ID: 12174055
    [Abstract] [Full Text] [Related]

  • 15. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
    Kouris A, Vavouli C, Markantoni V, Kontochristopoulos G.
    J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
    [Abstract] [Full Text] [Related]

  • 16. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E.
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [Abstract] [Full Text] [Related]

  • 17. Treatment of plantar hyperhidrosis with botulinum toxin type A.
    Vadoud-Seyedi J.
    Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk.
    Kim WO, Kil HK, Yoon KB, Noh KU.
    Dermatol Surg; 2009 May; 35(5):833-8; discussion 838. PubMed ID: 19389096
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 20. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N, Bernardini N, La Torre G, La Viola G, Potenza C.
    Acta Dermatovenerol Croat; 2011 Apr; 19(1):16-20. PubMed ID: 21489361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.